{"title":"Correction to: May Measurement Month 2017: screening for hypertension in Nigeria-Sub-Saharan Africa.","authors":"","doi":"10.1093/eurheartjsupp/suag069","DOIUrl":"https://doi.org/10.1093/eurheartjsupp/suag069","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1093/eurheartjsupp/suz064.].</p>","PeriodicalId":11956,"journal":{"name":"European Heart Journal Supplements","volume":"21 Suppl D","pages":"D134"},"PeriodicalIF":2.7,"publicationDate":"2026-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13312279/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148351090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Carmine Riccio, Francesco Fattirolli, Marco Ambrosetti, Giovanna Geraci, Massimo Milli, Maurizio Giuseppe Abrignani, Maria Elisabetta Angelino, Michela Barisone, Barbara Biffi, Arturo Cesaro, Maurizio de Giovanni, Stefania Angela Di Fusco, Andrea Di Lenarda, Antonio Mazza, Damiano Parretti, Donatella Radini, Matteo Ruzzolini, Simonetta Scalvini, Pietro Scicchitano, Elio Venturini, Claudio Bilato, Pasqualina Calisi, Marco Corda, Leonardo De Luca, Massimo Di Marco, Attilio Iacovoni, Francesco Maranta, Alessandro Navazio, Vittorio Pascale, Massimo Pistono, Emanuele Tizzani, Marika Werren, Michele Massimo Gulizia, Federico Nardi, Domenico Gabrielli, Furio Colivicchi, Massimo Grimaldi, Fabrizio Oliva
{"title":"Position paper ANMCO in collaboration with Italian Alliance for Cardiovascular Rehabilitation and Prevention (ITACARE-P): 'the management of hospital discharge'.","authors":"Carmine Riccio, Francesco Fattirolli, Marco Ambrosetti, Giovanna Geraci, Massimo Milli, Maurizio Giuseppe Abrignani, Maria Elisabetta Angelino, Michela Barisone, Barbara Biffi, Arturo Cesaro, Maurizio de Giovanni, Stefania Angela Di Fusco, Andrea Di Lenarda, Antonio Mazza, Damiano Parretti, Donatella Radini, Matteo Ruzzolini, Simonetta Scalvini, Pietro Scicchitano, Elio Venturini, Claudio Bilato, Pasqualina Calisi, Marco Corda, Leonardo De Luca, Massimo Di Marco, Attilio Iacovoni, Francesco Maranta, Alessandro Navazio, Vittorio Pascale, Massimo Pistono, Emanuele Tizzani, Marika Werren, Michele Massimo Gulizia, Federico Nardi, Domenico Gabrielli, Furio Colivicchi, Massimo Grimaldi, Fabrizio Oliva","doi":"10.1093/eurheartjsupp/suag055","DOIUrl":"10.1093/eurheartjsupp/suag055","url":null,"abstract":"<p><p>Hospital discharge is a pivotal stage in the continuum of care, marking the transition from the acute clinical episode to subsequent therapeutic management. Rather than being a purely administrative procedure, discharge is a multifaceted process that requires structured planning, clear communication, and the coordinated participation of all healthcare stakeholders, with the patient playing a central role. Inadequate discharge processes may adversely affect clinical outcomes and increase hospital readmission rates, resulting in sub-optimal utilization of healthcare resources. This issue is particularly relevant in the context of an ageing and increasingly frail population, characterized by a high burden of comorbidities and complex clinical needs. In this setting, discharge planning should be treated as an integral component of the care pathway, embedded within a comprehensive, coordinated model of care. This document proposes an updated, practical framework for hospital discharge management, grounded in current scientific evidence and multidisciplinary expertise. Its primary objective is to enhance continuity of care, support individualized treatment strategies, and ultimately improve patient outcomes. Specifically, this paper aims to provide clinical cardiologists with a structured reference tool for discharge management, including actionable recommendations to strengthen physician-patient communication, optimize therapeutic regimens, and promote better health outcomes.</p>","PeriodicalId":11956,"journal":{"name":"European Heart Journal Supplements","volume":"28 Suppl 6","pages":"vi249-vi271"},"PeriodicalIF":2.7,"publicationDate":"2026-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13151031/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147867252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Fabiana Lucà, Gian Franco Gensini, Francesco Gabbrielli, Daniela Aschieri, Michela Barisone, Ilaria Battistoni, Francesco Antonio Benedetto, Claudio Bilato, Giovanni Bisignani, Roberto Ceravolo, Vincenzo Ciconte, Silvana De Bonis, Leonardo De Luca, Stefania Angela Di Fusco, Andrea Di Lenarda, Sandro Gelsomino, Giovanna Geraci, Vered Gil Ad, Mauro Gori, Attilio Iacovoni, Barbara Maria Teresa Mabritto, Massimo Milli, Iris Parrini, Annarita Pilleri, Andrea Pozzi, Carmelo Massimiliano Rao, Carmine Riccio, Patrizia Rocca, Pietro Scicchitano, Marco Vatrano, Francesco Vigorito, Michele Massimo Gulizia, Furio Colivicchi, Domenico Gabrielli, Fabrizio Oliva, Federico Nardi, Massimo Grimaldi
{"title":"ANMCO position paper E-health integration in cardiology clinical care framework.","authors":"Fabiana Lucà, Gian Franco Gensini, Francesco Gabbrielli, Daniela Aschieri, Michela Barisone, Ilaria Battistoni, Francesco Antonio Benedetto, Claudio Bilato, Giovanni Bisignani, Roberto Ceravolo, Vincenzo Ciconte, Silvana De Bonis, Leonardo De Luca, Stefania Angela Di Fusco, Andrea Di Lenarda, Sandro Gelsomino, Giovanna Geraci, Vered Gil Ad, Mauro Gori, Attilio Iacovoni, Barbara Maria Teresa Mabritto, Massimo Milli, Iris Parrini, Annarita Pilleri, Andrea Pozzi, Carmelo Massimiliano Rao, Carmine Riccio, Patrizia Rocca, Pietro Scicchitano, Marco Vatrano, Francesco Vigorito, Michele Massimo Gulizia, Furio Colivicchi, Domenico Gabrielli, Fabrizio Oliva, Federico Nardi, Massimo Grimaldi","doi":"10.1093/eurheartjsupp/suag061","DOIUrl":"10.1093/eurheartjsupp/suag061","url":null,"abstract":"<p><p>The ongoing digital transformation is reshaping organisational and care delivery models in cardiology, positioning telemedicine as a pivotal tool to address increasing clinical and demographic complexity. This manuscript presents a comprehensive and critical overview of telemedicine applications in cardiovascular care, with a focus on its role in strengthening hospital-community integration, its deployment within hospital-based healthcare systems, and the associated regulatory and operational frameworks. The analysis encompasses the management of chronic cardiovascular conditions, such as heart failure and atrial fibrillation, through telemonitoring, telecontrol, televisit, and teleconsultation. Additionally, it explores the use of digital technologies in post-myocardial infarction follow-up, oral anticoagulation management, preoperative assessment, and care for elderly patients. The review also highlights the challenges and opportunities linked to digital infrastructure, interoperability, data protection, and healthcare professional training.</p>","PeriodicalId":11956,"journal":{"name":"European Heart Journal Supplements","volume":"28 Suppl 6","pages":"vi286-vi303"},"PeriodicalIF":2.7,"publicationDate":"2026-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13151029/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147867260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Simona Giubilato, Pietro Scicchitano, Claudio Bilato, Marco Corda, Leonardo De Luca, Massimo Di Marco, Giovanna Geraci, Attilio Iacovoni, Massimo Milli, Alessandro Navazio, Vittorio Pascale, Carmine Riccio, Emanuele Tizzani, Filippo Zilio, Antonio Di Monaco, Federico Nardi, Domenico Gabrielli, Furio Colivicchi, Massimo Grimaldi, Fabrizio Oliva
{"title":"ANMCO position paper: ANMCO general assembly 2024-the role of the cardiologist in the management of cardiovascular chronicity.","authors":"Simona Giubilato, Pietro Scicchitano, Claudio Bilato, Marco Corda, Leonardo De Luca, Massimo Di Marco, Giovanna Geraci, Attilio Iacovoni, Massimo Milli, Alessandro Navazio, Vittorio Pascale, Carmine Riccio, Emanuele Tizzani, Filippo Zilio, Antonio Di Monaco, Federico Nardi, Domenico Gabrielli, Furio Colivicchi, Massimo Grimaldi, Fabrizio Oliva","doi":"10.1093/eurheartjsupp/suag062","DOIUrl":"10.1093/eurheartjsupp/suag062","url":null,"abstract":"<p><p>Cardiovascular diseases remain the leading cause of mortality globally and in Italy, with a growing burden exacerbated by ageing populations and underdeveloped strategies for managing chronic cardiovascular conditions. This position paper, resulting from the 2024 ANMCO General Assembly, addresses the current state of cardiovascular chronicity management in Italy, highlighting critical gaps and proposing sustainable, integrative solutions. Despite improvements in acute cardiovascular care, the lack of structured post-acute management, insufficient adoption of secondary prevention protocols, limited access to innovative therapies, and a slow digital transition continue to hinder effective chronic care. The document stresses the pivotal role of cardiologists, not only in acute intervention but also in long-term care and secondary prevention, emphasising the need for a multidisciplinary, multichannel healthcare model. The paper explores the potential of e-Health and artificial intelligence to revolutionize chronic disease management. It advocates for the widespread implementation of integrated care pathways, digital tools like electronic health records and telemedicine platforms, which together could enhance early detection, patient monitoring, and therapeutic adherence while reducing unnecessary hospitalisations. It also underscores the necessity of updating national and regional pharmaceutical policies to improve equitable access to disease-modifying therapies. Furthermore, the integration of palliative care in end-stage cardiovascular disease and the enhancement of post-acute care networks are deemed essential. Ultimately, the document advocates for a comprehensive systemic and cultural transformation spearheaded by scientific societies such as ANMCO, where technological innovation, organisational reform, and patient-centred care align to ensure a sustainable and universally accessible healthcare system. This vision is consistent with the objectives of the PNRR, the 2030 Agenda, and, most importantly, the foundational principles of the Italian Constitution.</p>","PeriodicalId":11956,"journal":{"name":"European Heart Journal Supplements","volume":"28 Suppl 6","pages":"vi272-vi285"},"PeriodicalIF":2.7,"publicationDate":"2026-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13151026/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147867255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Fabiana Lucà, Eugenio Picano, Daniela Aschieri, Ilaria Battistoni, Claudio Bilato, Stefania Angela Di Fusco, Giovanna Geraci, Vered Gil Ad, Attilio Iacovoni, Barbara Maria Teresa Mabritto, Massimo Milli, Pietro Scicchitano, Federica Troisi, Francesco Vigorito, Domenico Gabrielli, Michele Massimo Gulizia, Furio Colivicchi, Fabrizio Oliva, Federico Nardi, Massimo Grimaldi
{"title":"Occupational Hazards in Cardiac Catheterization Laboratories: Radiation and Beyond-ANMCO Position Paper Update 2026.","authors":"Fabiana Lucà, Eugenio Picano, Daniela Aschieri, Ilaria Battistoni, Claudio Bilato, Stefania Angela Di Fusco, Giovanna Geraci, Vered Gil Ad, Attilio Iacovoni, Barbara Maria Teresa Mabritto, Massimo Milli, Pietro Scicchitano, Federica Troisi, Francesco Vigorito, Domenico Gabrielli, Michele Massimo Gulizia, Furio Colivicchi, Fabrizio Oliva, Federico Nardi, Massimo Grimaldi","doi":"10.1093/eurheartjsupp/suag063","DOIUrl":"10.1093/eurheartjsupp/suag063","url":null,"abstract":"<p><p>Interventional cardiology has profoundly transformed the management of cardiovascular disease; however, working within the cardiac catheterization laboratory exposes healthcare professionals to substantial occupational hazards. Four principal risks can be identified: (i) malignancy and non-malignant sequelae related to chronic exposure to ionizing radiation; (ii) musculoskeletal injury associated with prolonged use of heavy radioprotective equipment; (iii) exposure to blood-borne pathogens and other infectious agents; and (iv) work-related psychological strain. Among these, cumulative radiation exposure remains the most consequential and historically under-recognized threat. Although the radiation dose which operators receive during a single procedure is markedly lower than that delivered to patients, healthcare professionals are subjected to repeated, lifelong exposure. For a high-volume interventional cardiologist, the annual effective dose may substantially exceed that of other radiation-exposed professionals, including nuclear industry workers and diagnostic radiologists. Importantly, unlike radiologists, many cardiologists receive limited formal training in radiation physics and radiobiology, which may lead to limited awareness of dose-optimization strategies and stochastic risk. Contemporary epidemiological evidence has refined our understanding of the biological effects of chronic low-dose and low-dose-rate radiation. Risk estimates for malignancy have progressively increased as follow-up durations have lengthened and methodological approaches have improved. Moreover, emerging data suggest that sustained low-dose exposure may confer an elevated risk of cardiovascular disease, thereby extending concern beyond oncological endpoints. Occupational exposure varies greatly depending on the location: doses to the head can be several times higher than doses to the chest, with a predominance on the left side attributable to the position of the operator in relation to the X-ray source. In addition to the well-established association with posterior subcapsular cataracts, observational studies have reported potential links between long-term occupational exposure and neurodegenerative disorders, including Alzheimer's and Parkinson's diseases, although causality remains to be definitively established. Mitigation of these risks necessitates a paradigm shift towards a rigorous culture of radiation safety. Institutional commitment is essential, encompassing advanced shielding systems, ceiling-suspended protection, real-time dosimetry with immediate feedback, and systematic optimization of imaging protocols. Ultimately, the future of the field may depend on the progressive adoption of radiation-sparing and radiation-free technologies, including intracardiac and intracoronary ultrasound, electro anatomical mapping systems, and non-fluoroscopic navigation platforms. In parallel, robot-assisted procedures enable remote manipulation of the catheter promis","PeriodicalId":11956,"journal":{"name":"European Heart Journal Supplements","volume":"28 Suppl 6","pages":"vi304-vi314"},"PeriodicalIF":2.7,"publicationDate":"2026-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13151030/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147867268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Impella™-protected PCI in a post-CABG patient with advanced biventricular dysfunction and mitral regurgitation.","authors":"Mohamed Ayoub, Saad Ezad, Roberto Lorusso, Pieter Vriesendorp, Christophe Vandenbriele, Vasileios Panoulas","doi":"10.1093/eurheartjsupp/suag066","DOIUrl":"10.1093/eurheartjsupp/suag066","url":null,"abstract":"<p><p>Patients with advanced coronary artery disease (CAD), severely reduced left ventricular (LV) ejection fraction, and prior coronary artery bypass grafting (CABG) present with complex revascularization challenges requiring individualized, multidisciplinary decision-making and pre-procedural strategy planning. Protected percutaneous coronary intervention (PCI) using percutaneous temporary mechanical circulatory support, such as the Impella™ microaxial flow pump, may enable complex revascularization in carefully selected patients at high risk of peri-procedural haemodynamic compromise. We describe a male patient with advanced ischaemic cardiomyopathy, severe functional mitral regurgitation, and complex multivessel CAD, including chronic total occlusion (CTO) of the left anterior descending artery, following prior CABG. After Heart Team discussion and in the context of prohibitive surgical risk, a staged strategy was carefully planned pre-procedurally and then pursued with mitral transcatheter edge-to-edge repair, followed by prophylactic Impella-assisted PCI. Under haemodynamic support, retrograde CTO PCI via a patent saphenous vein graft was performed with drug-eluting stent implantation and intravascular ultrasound-confirmed optimization, achieving TIMI 3 flow. The patient remained haemodynamically stable, with an uneventful post-procedural course and no vascular or cardiac complications. This case illustrates how a staged Impella-protected PCI strategy can facilitate revascularization in post-CABG patients with advanced LV dysfunction and be integrated into a timely, planned, and patient-tailored approach accounting for ventricular function, valvular disease, and complex coronary anatomy when surgery is not feasible.</p>","PeriodicalId":11956,"journal":{"name":"European Heart Journal Supplements","volume":"28 Suppl 7","pages":"vii58-vii67"},"PeriodicalIF":2.7,"publicationDate":"2026-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13294563/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148344287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Helge Möllmann, Marcel Weber, Maria Isabel Körber, Theresa Ann-Maria Gößler, Tobias Friedrich Ruf, Hannah Kempton, Paolo Denti, Rodrigo Estevez-Loureiro, Christina Grothusen, Volker Rudolph, Jörg Hausleiter, Holger Thiele
{"title":"Focus on tricuspid valve-the European perspective.","authors":"Helge Möllmann, Marcel Weber, Maria Isabel Körber, Theresa Ann-Maria Gößler, Tobias Friedrich Ruf, Hannah Kempton, Paolo Denti, Rodrigo Estevez-Loureiro, Christina Grothusen, Volker Rudolph, Jörg Hausleiter, Holger Thiele","doi":"10.1093/eurheartjsupp/suaf099","DOIUrl":"10.1093/eurheartjsupp/suaf099","url":null,"abstract":"<p><p>Tricuspid regurgitation (TR) affects approximately 4% of individuals over 75 years of age and is associated with substantial morbidity due to heart failure symptoms and frequent hospitalization. In Europe, TR prevalence is expected to rise with an ageing population, contributing to a growing burden on heart failure services. Surgical repair or replacement for isolated TR has been historically underutilized because of high operative risk, however, recent advancements in transcatheter technology have shifted the treatment paradigm. Having once been labelled the forgotten valve, the European interventional cardiology community was suddenly confronted with a number of different devices, all designed to target TR. Having the intrahospital mortality for isolated tricuspid valve surgery in mind, ranging from 8.0% to 12.3%, the initial results of transcatheter therapies with an all-cause mortality of 3.7% at 30 days were promising, although procedural success was achieved in only 62% and cardiac and cerebrovascular major adverse events were as high as 26%. Already, T-TEER constituted the majority of interventions, although miskeyed M-TEER devices were used off-label. Other systems, such as Trialign, TriCinch, FORMA, Cardioband, NaviGate, and caval valve implantation were used distinctively less often.</p>","PeriodicalId":11956,"journal":{"name":"European Heart Journal Supplements","volume":"28 Suppl 4","pages":"iv70-iv82"},"PeriodicalIF":2.7,"publicationDate":"2026-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13128270/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147812789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Renal failure isn't just a nephrologist problem.","authors":"Gennaro Cice","doi":"10.1093/eurheartjsupp/suag038","DOIUrl":"10.1093/eurheartjsupp/suag038","url":null,"abstract":"<p><p>In the collective perception, uraemic patients are often identified as those undergoing dialysis. In reality, however, dialysis patients represent only a small fraction of the total uraemic population. Conservative estimates indicate that one in ten individuals in the industrialized world has some degree of renal dysfunction, meaning that approximately 700 million people are affected [GBD-Chronic Kidney Disease Collaboration. Global, regional, and national burden of Chronic Kidney Disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. <i>Lancet</i> 2020;395:709-33]. These figures have rapidly made chronic kidney disease (CKD)-the correct term for renal failure-a global public health issue, owing both to its unsustainable economic burden for healthcare systems and its high mortality rate, estimated at 2.6 million deaths in 2017 [Saran R, Robinson B, Abbott KC, Bragg-Gresham J, Chen X, Gipson D <i>et al.</i> US Renal Data System 2019 annual data report: epidemiology of kidney disease in the United States. <i>Am J Kidney disease</i> 2020;75:S1-S64]. To mitigate the impact of this true epidemic, new strategies must prioritize early detection and prevention. The first step, however, is conceptual: CKD should no longer be regarded as an exclusively nephrological disorder but as a multisystem condition requiring the attention of internists, cardiologists, diabetologists, and general practitioners alike.</p>","PeriodicalId":11956,"journal":{"name":"European Heart Journal Supplements","volume":"28 Suppl 5","pages":"v87-v90"},"PeriodicalIF":2.7,"publicationDate":"2026-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13147244/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147835136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Francesco Prati, Andrea Giovagnoli, Giulia Paoletti, Michela Ferrari, Flavio Giuseppe Biccirè, Laura Gatto, Paolo Pavone
{"title":"First scan, then treat: 10 years of the SCOT-HEART study.","authors":"Francesco Prati, Andrea Giovagnoli, Giulia Paoletti, Michela Ferrari, Flavio Giuseppe Biccirè, Laura Gatto, Paolo Pavone","doi":"10.1093/eurheartjsupp/suag042","DOIUrl":"10.1093/eurheartjsupp/suag042","url":null,"abstract":"<p><p>The widespread use of coronary computed tomography (CT) to exclude significant coronary stenoses and, more broadly, to achieve a more accurate assessment of cardiovascular risk through the evaluation of atherosclerosis has gained momentum in recent years, largely driven by growing criticism of the traditional ischaemia-centred paradigm. The SCOT-HEART studies were among the first large randomized trials to promote the use of coronary CT in patients presenting with angina. The information provided by coronary CT translated into improved clinical outcomes through the adoption of more aggressive medical therapy, particularly lipid-lowering treatment, which was selectively prescribed to patients with evidence of atherosclerosis. The results of the SCOT-HEART 2 primary prevention trial are eagerly awaited and may further influence clinical practice. Finally, photon-counting CT, representing the latest technological advance, together with the application of artificial intelligence-based image analysis algorithms, may constitute an additional step forward in the use of CT imaging.</p>","PeriodicalId":11956,"journal":{"name":"European Heart Journal Supplements","volume":"28 Suppl 5","pages":"v143-v147"},"PeriodicalIF":2.7,"publicationDate":"2026-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13147259/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147835329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}